Clinical and imaging correlates of response to treatment with infliximab in patients with ankylosing spondylitis

Journal of Rheumatology

Volumn 28, Issue 7, 2001, Pages 1605-1614

  Stone, M ^a   Salonen, D ^a   Lax, M ^a   Payne, U ^a   Lapp, V ^a   Inman, R ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Ankylosing spondylitis; Infliximab; Magnetic resonance imaging; Tumor necrosis factor

Indexed keywords

CORTICOSTEROID; GADOLINIUM; INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTRAST ENHANCEMENT; DISEASE ACTIVITY; FEMALE; HUMAN; IMAGING; MALE; PRIORITY JOURNAL; SCORING SYSTEM; TREATMENT OUTCOME;

ACHILLES TENDON; ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; COHORT STUDIES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SPONDYLITIS, ANKYLOSING; TENDINOPATHY; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034944634     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Pathogenesis of spondylarthropathies; persistent bacterial antigen, autoimmunity, or both?
2. Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: A Department of Veterans Affairs cooperative study
3. Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor a monoclonal antibody infliximab
4. Effects of a loading dose regimen of 3 infusions of chimeric monoclonal antibody to tumor necrosis factor a (infliximab) in spondyloarthropathy: An open pilot study
5. Tumor necrosis factor receptor p55 controls severity of arthritis in experimental Yersinia enterocolitica infection
6. Association of different tumor necrosis factor a promoter allele frequencies with ankylosing spondylitis in HLA-B27 positive individuals
7. The -308.1 polymorphism in the promoter region of the tumor necrosis factor alpha promoter allele frequencies with ankylosing spondylitis in HLA-B27 positive individuals
8. Use of immunohistologic and in situ hybridization techniques in the examination of SI joint biopsy specimens from patients with ankylosing spondylitis
9. Lack of correlation between clinical disease activity and erythrocyte sedimentation rate, acute phase proteins or protease inhibitors in ankylosing spondylitis
10. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis
11. Serum amyloid A - An indicator of inflammation in ankylosing spondylitis
12. A new approach to defining disease status in ankylosing spondylitis: The bath ankylosing spondylitis disease activity index
13. Imaging of SI joints
14. Magnetic resonance imaging in rheumatic disorders of the spine and SI joints
15. Use of magnetic resonance imaging to detect spinal inflammation in spondyloarthropathy patients
16. Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients
17. Determination of the best diagnostic criteria of sacroiliitis with MRI
18. Early sacroiliitis in patients with sacroiliits: Evaluation with dynamic gadolinium-enhanced MRI
19. Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis - Cellularity correlates with the degree of enhancement detected by magnetic resonance imaging
20. Evaluation of diagnostic criteria for ankylosing spondylitis: A proposal for modification of the New York criteria
21. A new approach to defining functional ability in ankylosing spondylitis: The development of the bath ankylosing spondylitis functional index
22. Evaluation of a functional index for patients with ankylosing spondylitis
23. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus
24. Measurement of patient outcome in arthritis
25. Construction and initial characterization of a mouse-human chimeric anti-TNF antibody
26. TNF-alpha-induced endothelium-independent vasodilation: A role for phospholipase A2-dependent ceramide signaling
27. Regulation of cytokines, cytokine inhibitors and acute-phase proteins following anti-TNFa therapy in rheumatoid arthritis
28. Infliximab for the treatment of fistulas in patients with Crohn's disease
29. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor a monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis
30. Infliximab (chimeric anti-tumor necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase 111
31. The European Spondyloarthropathy Study Group preliminary criteria for the classification of spondyloarthropathy
32. Comparison of radiography, computed tomography and magnetic resonance imaging in the detection of sacroiliitis accompanying ankylosing spondylitis
33. Retrocalcaneal bursitis in spondyloarthropathy: Assessment by ultrasonography and magnetic resonance imaging